TCF12/HEB Antibody [G2F21]

N.º de catálogo F6098

Imprimir

Descripción biológica

Especificidad TCF12/HEB Antibody [G2F21] detecta niveles endógenos de proteína TCF12/HEB total.
Antecedentes TCF12/HEB (Factor de Transcripción 12/proteína de unión a la caja E de HeLa) es un factor de transcripción de hélice-bucle-hélice básico (bHLH) de proteína E de clase I codificado por TCF12 en el cromosoma 15q21, que existe en dos isoformas principales: HEBCan (681 aminoácidos, del promotor ubicuo) y HEBAlt (forma corta, de un promotor distal). Estas isoformas heterodimerizan con socios bHLH específicos de tejido como E47, MyoD y NeuroD a través de su dominio bHLH conservado, que consta de una región básica de unión a ADN y un motivo HLH para la dimerización, para reconocer secuencias consenso CANNTG E-box, impulsando así el compromiso de linaje en células T/B, músculo y neuronas. TCF12/HEB contiene un dominio de activación N-terminal rico en residuos ácidos para el reclutamiento de coactivadores, un dominio de transactivación central con tramos de glutamina/prolina que mejoran la pausa y liberación de la ARN polimerasa II, el dominio bHLH central (~60 residuos) donde la hélice básica contacta con el surco mayor del ADN mientras que las hélices anfipáticas HLH dimerizan a través de interfaces hidrofóbicas, y dominios inhibidores C-terminales que modulan la especificidad del socio. El splicing alternativo en el exón 1 genera HEBCan para etapas amplias del desarrollo de células T y HEBAlt, que está enriquecido en timocitos DN2/DN3 para promover una generación eficiente de precursores. TCF12/HEB orquesta el desarrollo de células T co-uniéndose a Lmo2 y Lyl1 en los potenciadores Eβ y Cd4 para activar genes involucrados en la recombinación y expansión, reprime los objetivos de E2A a través de la dimerización competitiva para limitar la autorrenovación, y equilibra la reconstitución versus diferenciación de células madre hematopoyéticas (HSC), con una deficiencia que resulta en sesgo mieloide, bloqueo de células B/T y defectos de proliferación. La señalización de PKCθ/Carma1 fosforila HEBCan en residuos de serina, aliviando la autoinhibición mediada por la proteína Id y permitiendo el bucle de cromatina inducido por TCR con Runx1 y Foxp1 para la expresión de Il2ra y Dtx1, mientras que HEBAlt se asocia únicamente con Bcl11b en el potenciador Tcrα para facilitar la selección positiva. Las mutaciones de TCF12 causan craneosinostosis coronal (síndrome de Saethre-Chotzen) al interrumpir la heterodimerización de Twist1 y la permeabilidad de la sutura; la haploinsuficiencia está relacionada con la dislexia a través de la desregulación de genes del neurodesarrollo, y las alteraciones somáticas contribuyen a la leucemia (fusiones AML1-ETO) o a la progresión de tumores sólidos a través de EMT e invasión.

Información de uso

Aplicación WB, IP, IHC Dilución
WB IP IHC
1:1000 1:50 1:200 - 1:800
Reactividad Human
Fuente Rabbit Monoclonal Antibody MW 85 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/28803914/
  • https://pubmed.ncbi.nlm.nih.gov/35399207/

Datos de aplicación

WB

Validado por Selleck

  • F6098-wb
    Lane 1: IMR-32, Lane 2: Jurkat, Lane 3: MOLT4